Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Concentrix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Concentrix's regulatory disclosures and financial reporting.
Concentrix Corp reported that President and CEO Christopher A. Caldwell received an equity award in the form of restricted stock units. On 01/21/2026, he was granted 93,291 shares of common stock at a price of $0 per share, increasing his directly held beneficial ownership to 373,877 common shares after the award.
The filing explains that these 93,291 units are restricted stock units granted under the company’s 2020 Stock Incentive Plan. The units are scheduled to vest in three equal installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date, tying the CEO’s compensation to the company’s long‑term performance.
Concentrix Corp executive Jane Fogarty, EVP, Legal, reported an equity award of common stock on a Form 4. On January 21, 2026, she acquired 13,913 shares of Concentrix common stock at a price of $0 per share, reflecting a grant of restricted stock units under the company’s 2020 Stock Incentive Plan.
The restricted stock units vest in three equal installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date. Following this award, Fogarty beneficially owns 33,044 shares of Concentrix common stock directly.
Concentrix Corp executive Gibson Craig reported an equity award of company stock. On January 21, 2026, he received 15,015 shares of Common Stock at a price of $0 per share, reported as an acquisition. After this grant, he beneficially owned 56,023 shares of Concentrix Common Stock in total, held directly.
According to the footnote, the award represents restricted stock units granted under the 2020 Stock Incentive Plan. These restricted stock units vest in stages, with one-third of the shares vesting on each of the first three anniversaries of the grant date, meaning the executive earns the shares over a three-year period tied to continued service.
Concentrix Corp Chief Financial Officer reports stock award. CFO Valentine Andre S reported receiving 25,694 shares of Concentrix common stock on 01/21/2026, recorded at a price of $0 per share as an equity grant. These shares are in the form of restricted stock units awarded under the company’s 2020 Stock Incentive Plan. The units are scheduled to vest in three equal installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date. Following this grant, the CFO beneficially owns 89,560 shares of Concentrix common stock, held directly.
Concentrix Corp. executive Cormac J. Twomey reported a stock-based compensation grant. On January 21, 2026, he acquired 26,724 shares of Common Stock of Concentrix Corp. through an award of restricted stock units under the company’s 2020 Stock Incentive Plan at a stated price of $0 per share. Following this grant, he beneficially owns 61,854 shares of Concentrix Common Stock in direct ownership. The restricted stock units vest in three equal annual installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date, linking the award to continued service over time.
Concentrix Corporation filed a current report to let investors know it has released its financial results for the quarter and year ended November 30, 2025. The company reported these results through a press release dated January 13, 2026, which is included in the filing as Exhibit 99.1.
The company notes that this information is being furnished under the SEC’s Item 2.02 for results of operations and financial condition, meaning it is provided for disclosure purposes and is not treated as formally filed for liability purposes under certain securities laws.
Concentrix Corporation (CNXC) reported an insider purchase by a reporting person who serves as President and CEO and Director. On 10/31/2025, the insider bought 1,000 shares of Common Stock at a price of $40 per share (Transaction Code: P), held as Direct (D) ownership. Following the transaction, the insider beneficially owns 287,661 shares.
Concentrix (CNXC) insider filing reports two transactions by the company’s President and CEO, who also serves as a Director. On 10/29/2025, the reporting person made a bona fide gift of 20,684 shares of common stock at $0, described as a transfer to a family trust in which the reporting person has no beneficial or pecuniary interest. Following this gift, the filing shows 284,661 shares held directly.
On 10/30/2025, the reporting person purchased 2,000 common shares at an average price of $42.0279, bringing direct beneficial ownership to 286,661 shares. Both holdings are reported as Direct (D) ownership.
Concentrix Corp (CNXC) reported an insider transaction by its EVP, Global Ops & Delivery. On October 30, 2025, the officer sold 500 shares of common stock at $42.53 per share. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025.
Following this transaction, the reporting person beneficially owns 35,630 shares, held directly. This is a routine Form 4 disclosure of an executive’s equity transaction under a pre-established plan.
Concentrix (CNXC) reported an insider transaction by an executive officer. On 10/27/2025, a Form 4 shows a code F disposition of 1,403 shares of common stock at $46.04. After this transaction, the reporting person directly beneficially owns 41,008 shares. The filer is listed as EVP, Global Sales, Acct Mgmt, and the filing was made by one reporting person.